UPDATE 1-J&J beats forecasts, helped by new hepatitis C drug
July 15, 2014 at 08:35 AM EDT
July 15 (Reuters) - Johnson & Johnson reported higher-than-expected quarterly revenue and earnings, benefiting from strong sales of its Olysio treatment for hepatitis C.
